PUMA BIOTECHNOLOGY, INC.·4

Aug 13, 9:09 PM ET

MILLER MICHAEL PATRICK 4

4 · PUMA BIOTECHNOLOGY, INC. · Filed Aug 13, 2024

Insider Transaction Report

Form 4
Period: 2024-08-12
Transactions
  • Sale

    Common Stock

    2024-08-12$3.49/sh23,358$81,46647,000 total
Footnotes (2)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.4201 to $3.5501, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  • [F2]Corrects the amount that was erroneously reported as held in the Form 4 filed on June 21, 2024 with the Securities and Exchange Commission.

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    FORM 4